Edesa Biotech (EDSA) Acquisitions (2019 - 2020)
Edesa Biotech (EDSA) posted Acquisitions of -$6.4 million for Q3 2020, down 200.0% sequentially from $6.4 million in Q2 2019.
Edesa Biotech (EDSA) Acquisitions (2019 - 2020) Analysis & Trends
Edesa Biotech has reported Acquisitions for 2 years, with the latest figure at -$6.4 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | - |
| 10 | Edesa Biotech | 42.25 Mn | 42.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -6.39 Mn |
| Jun 30, 2019 | 6.39 Mn |